In Silico Research in Biomedicine
Elsevier · Netherlands
Aims & Scope✦ Inferred from recent articles
This journal focuses on computational research in biomedicine, particularly employing in silico methods for drug discovery and development. Studies involve molecular docking, molecular dynamics simulations, network pharmacology, and pharmacokinetic property predictions to identify potential therapeutic agents, understand biological mechanisms, and optimize drug candidates. Research areas include cancer, infectious diseases, immune checkpoints, and aging.
AI-summarised from recent articles · verify on publisher page →
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Subject Classification
Research Topics (OpenAlex)
Frequently asked questions about In Silico Research in Biomedicine
Is In Silico Research in Biomedicine a predatory journal?
PubScope has no integrity flags on record for In Silico Research in Biomedicine: it is indexed in DOAJ, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of In Silico Research in Biomedicine?
In Silico Research in Biomedicine is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor.
Is In Silico Research in Biomedicine indexed in Scopus and Web of Science?
In Silico Research in Biomedicine is indexed in DOAJ.
You May Also Like
See all →Data updated: 2026-05-26 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref